Diagnosis or drug? Will pharmaceutical companies or diagnostics manufacturers earn more from personalized medicine?

doi:10.1038/sj.embor.7401080

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Diagnosis or drug? Will pharmaceutical companies or diagnostics manufacturers earn more from personalized medicine?

EMBO reports - 1 Oct 2007

Kling Jim

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Evidence-Based Medicine
Share to Genetic Predisposition to Disease
Share to Molecular Diagnostic Techniques
Share to Pharmacogenetics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Open in PubMed Open full text

Identifiers

PMID: 17906670
DOI: 10.1038/sj.embor.7401080
PMCID: PMC2002567

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diagnosis or drug? Will pharmaceutical companies or diagnostics manufacturers earn more from personalized medicine?PMID 17906670Read ↗

Personalized medicine gets practical.Semantic proximity Read ↗

Integration of molecular diagnostics with therapeutics: implications for drug discovery and patient care.Semantic proximity Read ↗

Pharmacogenomics and personalized medicine: mapping of future value creation.Semantic proximity Read ↗

Improving the power of diagnostics in the era of targeted therapy and personalized healthcare.Semantic proximity Read ↗

Pharmacogenomics and diagnostics.Semantic proximity Read ↗

Pharmacogenomics: time to rethink its role in precision medicine.Semantic proximity Read ↗

Personalized medicine: the future of Modern MedicineSemantic proximity Read ↗

Foundations, promises and uncertainties of personalized medicine.Semantic proximity Read ↗

Medicine. Personalized cancer diagnostics.Semantic proximity Read ↗

Theranostics in primary care: pharmacogenomics tests and beyond.Semantic proximity Read ↗

Personalized medicine: are we there yet?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.